Table of Contents
Is cerebral being sued?
Cerebral “consistently and at times egregiously put profits and growth before patient safety,” Truebe alleged in the complaint filed in San Francisco Superior Court in California, which was first reported by Bloomberg Law. Mental health startup Cerebral is under investigation by the US Department of Justice over its prescribing of controlled substances like Adderall and Xanax. The company received a grand jury subpoena asking for documents from the US Attorney for the Eastern District of New York on May 4, Insider first reported. Cerebral under federal investigation for possible violations of controlled substances law. They allegedly instructed employees to prescribe stimulants to boost patient retention and failed to report data breaches, resulting in the ousting of their CEO and a new lawsuit claiming they “consistently and at times egregiously put profits and growth before patient safety.” These include staff reduction, reducing the number of company retreats and sunsetting certain programs such as care counseling, coaching and weight management. A source confirmed those details to BHB. Cerebral confirmed last month it would stop offering coaching and care counseling services.
What is the cerebral online therapy lawsuit?
Allegations of overprescribing at Cerebral The San Francisco-based company banked $300 million in a series C round in December, boosting its valuation to $4.8 billion. In the lawsuit, Truebe claims Cerebral leadership ignored serious concerns that he raised. Who invested in Cerebral ? Cerebral has 15 investors including Access Industries and WestCap . How much funding has Cerebral raised to date? Cerebral has raised $462M . Cerebral Inc., a provider of mental-health services, sued founder Kyle Robertson over his alleged refusal to repay more than half of a $49.8 million loan he took out from the SoftBank Group Corp. -backed company. Is Cerebral a legitimate company? Yes. Cerebral has licensed therapists in every U.S. state and Washington, D.C.